{
  "event_id": "d40e3f4c5356",
  "ticker": "ARGX",
  "company_name": "argenx",
  "drug_name": "SC Efgartigimod",
  "pdufa_date": "20251017",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:ADAPT-SC bridging study",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.139240",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Generalized myasthenia gravis (gMG) in AChR antibody-positive adults",
    "source": "websearch:ADAPT-SC bridging study",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.139241",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "efgartigimod alfa and hyaluronidase-qvfc",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Neurology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.487960",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Approved",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:ADAPT-SC bridging study",
    "confidence": 0.85,
    "evidence": [
      "ADAPT-SC bridging study"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.139227",
    "error": null
  },
  "p_value": {
    "status": "not_applicable",
    "value": null,
    "source": "websearch:ADAPT-SC bridging study",
    "confidence": 0.9,
    "evidence": [
      "Single-arm or accelerated approval - no comparator p-value"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.139234",
    "error": null
  },
  "p_value_numeric": null,
  "effect_size": {
    "status": "found",
    "value": "IgG reduction 66.4% (SC) vs 62.2% (IV); MG-ADL 2-point improvement 69.1%",
    "source": "websearch:ADAPT-SC bridging study",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.139236",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "phase3_study_names": [
    "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients With Myasthenia Gravis Having Generalized Muscle Weakness"
  ],
  "nct_ids": [
    "NCT03669588"
  ],
  "enrollment": {
    "count": 167,
    "type": "ACTUAL",
    "nct_id": "NCT03669588",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:25:03.898081"
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "prior_crl_reason": null,
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "result": "approved",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:28:13.619061",
  "enriched_at": "2026-01-12T08:49:20.990964",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "4fdffd1aa1da",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "mechanism_of_action": "FcRn inhibitor",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -85,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.509620",
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:49:11.086394",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Approves Subcutaneous Efgartigimod as Treatment for ... Priority drug SC efgartigimod wins US FD"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:49:12.530704",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "argenx Announces U.S. FDA Acceptance of Biologics License ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:49:13.847003",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA Approves Subcutaneous Efgartigimod as Treatment for ... Subcutaneous Efgartigimod in Front of th"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:49:15.149141",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-12T08:49:20.990184",
    "search_status": "CONFIRMED_NONE"
  }
}